Table 2.
Univariate and multivariate analysis for prognostic factors in cancer-specific survival of stage III/IV CRC patients
Variables | Univariate analysis
|
Multivariate analysis
|
||||
---|---|---|---|---|---|---|
HR | 95% CI | p-value | HR | 95% CI | p-value | |
Gender | 0.835 | 0.594–1.175 | 0.300 | |||
Age | 1.351 | 0.943–1.935 | 0.101 | |||
Tumor location | 1.188 | 0.843–1.676 | 0.326 | |||
Tumor size | 1.199 | 0.817–1.757 | 0.354 | |||
Tumor differentiation | 0.731 | 0.497–1.074 | 0.110 | |||
Ki-67 positivity | 0.914 | 0.629–1.328 | 0.638 | |||
Body mass index | 0.806 | 0.597–1.087 | 0.158 | |||
Tumor invasion | 1.595 | 1.097–2.319 | 0.015 | 1.341 | 0.920–1.955 | 0.127 |
Lymph node metastasis | 1.426 | 1.136–1.789 | 0.002 | 1.430 | 1.158–1.766 | 0.001 |
Distant metastasis | 3.507 | 2.425–5.071 | <0.001 | 3.243 | 2.232–4.712 | <0.001 |
Serum CEA level | 1.466 | 1.006–2.136 | 0.046 | 1.515 | 1.038–2.212 | 0.031 |
Fn level | 2.302 | 1.541–3.437 | <0.001 | 2.222 | 1.483–3.329 | <0.001 |
Abbreviations: Fn, Fusobacterium nucleatum; CRC, colorectal cancer; CEA, carcinoembryonic antigen; HR, hazard ratio; CI, confidence interval.